Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.

Abstract

Formulation of nanocrystals is a robust approach which can improve delivery of poorly water soluble drugs, a challenge pharmaceutical industry has been facing since long. Large scale production of nanocrystals is done by techniques like precipitation, media milling and, high pressure homogenization. Application of appropriate stabilizers along with drying accords long term stability and commercial viability to nanocrystals. These can be administered through oral, parenteral, pulmonary, dermal and ocular routes showing their high therapeutic applicability. They serve to target drug molecules in specific regions through size manipulation and surface modification. This review dwells upon the in-vivo fate and varying applications in addition to the facets of drug nanocrystals stated above.

DOI: 10.1016/j.jconrel.2014.03.030
02004002014201520162017
Citations per Year

344 Citations

Semantic Scholar estimates that this publication has 344 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Pawar2014EngineeredNT, title={Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.}, author={Vivek K Pawar and Yuvraj Singh and Jaya Gopal Meher and Siddharth Gupta and Manish K Chourasia}, journal={Journal of controlled release : official journal of the Controlled Release Society}, year={2014}, volume={183}, pages={51-66} }